Literature DB >> 2265468

Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue.

L M Forrester1, J D Hayes, R Millis, D Barnes, A L Harris, J J Schlager, G Powis, C R Wolf.   

Abstract

The level of expression of glutathione S-transferases (GSTs) and cytochrome P450s in breast tissue are potentially important determinants in both the susceptibility of this tissue to the mutagenic effects of chemical carcinogens and in the response of breast tumors to chemotherapy. In this study we have investigated the expression of these proteins in 41 tumor and surrounding normal breast tissue samples by measurement of substrate metabolism. Western blot analysis and immunohistochemistry. In addition, we have quantitated the concentration of alpha, mu and pi class GST subunits using radioimmunoassay. All three classes of GST were expressed in breast tissue. The pi and mu class enzymes preponderate. Both the polymorphic mu class GST as well as a further form, present in all individuals, were found in high concentration. The polymorphic mu class GST was expressed in approximately 50% of the samples, which is consistent with the frequency of this polymorphism in the population and therefore does not appear to be a factor in susceptibility to this disease. Interestingly, although levels of the alpha class GST were very low, in two tumor samples extremely high levels of the B1B1 subunit were detected. Immunohistochemical studies showed significant variability in the localization of the pi class of GST between normal epithelial cells, infiltrating plasma cells and tumor cells, and in some samples GST pi appeared to be almost absent from the tumor tissue. No direct, or inverse correlation was found between GST pi concentration determined by radioimmunoassay and estrogen receptor levels. However, when studied by immunohistochemistry estrogen receptor negative tumors did tend to have higher GST pi content. The only cytochrome P450 detectable by Western blot analysis was a member of the P450IIC gene family. This was apparently distinct from the P450IIC proteins expressed in the liver and was detected in normal and tumor tissues to a similar extent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265468     DOI: 10.1093/carcin/11.12.2163

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

Review 1.  Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach.

Authors:  R Millikan; E DeVoto; B Newman; D Savitz
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 2.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

3.  Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

Authors:  Jana Mladkova; Miloslav Sanda; Eva Matouskova; Irena Selicharova
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

4.  Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer.

Authors:  Walter H Pavicic; Martin Laguens; Silvina M Richard
Journal:  Mol Med       Date:  2009-03-06       Impact factor: 6.354

5.  Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes.

Authors:  C Torresan; M M C Oliveira; G T Torrezan; S F V de Oliveira; C S Abuázar; R Losi-Guembarovski; R S Lima; C A Urban; I J Cavalli; E M S F Ribeiro
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

Review 6.  The need for epidemiologic studies of in-situ carcinoma of the breast.

Authors:  R Millikan; L Dressler; J Geradts; M Graham
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 7.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

8.  Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Kan Xue; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Helge Stalsberg; Dao Li Gao; Ziding Feng; David B Thomas; Chu Chen
Journal:  Breast Cancer Res Treat       Date:  2007-07-12       Impact factor: 4.872

9.  The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer.

Authors:  Caroline M Woolston; Lei Zhang; Sarah J Storr; Ahmad Al-Attar; Mohamed Shehata; Ian O Ellis; Stephen Y Chan; Stewart G Martin
Journal:  Mod Pathol       Date:  2012-04-06       Impact factor: 7.842

10.  Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer.

Authors:  Jasmina-Ziva Cerne; Maja Pohar-Perme; Srdjan Novakovic; Snjezana Frkovic-Grazio; Vida Stegel; Ksenija Gersak
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.